Literature DB >> 28070841

Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software.

Gian Marco Conte1, Antonella Castellano1, Luisa Altabella1,2, Antonella Iadanza1, Marcello Cadioli1,3, Andrea Falini1, Nicoletta Anzalone4.   

Abstract

PURPOSE: Dynamic susceptibility contrast MRI (DSC) and dynamic contrast-enhanced MRI (DCE) are useful tools in the diagnosis and follow-up of brain gliomas; nevertheless, both techniques leave the open issue of data reproducibility. We evaluated the reproducibility of data obtained using two different commercial software for perfusion maps calculation and analysis, as one of the potential sources of variability can be the software itself.
METHODS: DSC and DCE analyses from 20 patients with gliomas were tested for both the intrasoftware (as intraobserver and interobserver reproducibility) and the intersoftware reproducibility, as well as the impact of different postprocessing choices [vascular input function (VIF) selection and deconvolution algorithms] on the quantification of perfusion biomarkers plasma volume (Vp), volume transfer constant (K trans) and rCBV. Data reproducibility was evaluated with the intraclass correlation coefficient (ICC) and Bland-Altman analysis.
RESULTS: For all the biomarkers, the intra- and interobserver reproducibility resulted in almost perfect agreement in each software, whereas for the intersoftware reproducibility the value ranged from 0.311 to 0.577, suggesting fair to moderate agreement; Bland-Altman analysis showed high dispersion of data, thus confirming these findings. Comparisons of different VIF estimation methods for DCE biomarkers resulted in ICC of 0.636 for K trans and 0.662 for Vp; comparison of two deconvolution algorithms in DSC resulted in an ICC of 0.999.
CONCLUSIONS: The use of single software ensures very good intraobserver and interobservers reproducibility. Caution should be taken when comparing data obtained using different software or different postprocessing within the same software, as reproducibility is not guaranteed anymore.

Entities:  

Keywords:  Dynamic contrast-enhanced MRI (DCE); Dynamic susceptibility contrast MRI (DSC); Gliomas; Perfusion weighted MRI; Reproducibility of findings; Vascular input function (VIF)

Mesh:

Substances:

Year:  2017        PMID: 28070841     DOI: 10.1007/s11547-016-0720-8

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  35 in total

1.  Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging.

Authors:  Rihyeon Kim; Seung Hong Choi; Tae Jin Yun; Soon-Tae Lee; Chul-Kee Park; Tae Min Kim; Ji-Hoon Kim; Sun-Won Park; Chul-Ho Sohn; Sung-Hye Park; Il Han Kim
Journal:  Eur Radiol       Date:  2016-06-29       Impact factor: 5.315

2.  Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions.

Authors:  Tobias Heye; Matthew S Davenport; Jeffrey J Horvath; Sebastian Feuerlein; Steven R Breault; Mustafa R Bashir; Elmar M Merkle; Daniel T Boll
Journal:  Radiology       Date:  2012-12-06       Impact factor: 11.105

3.  Differences in dynamic susceptibility contrast MR perfusion maps generated by different methods implemented in commercial software.

Authors:  Laura Orsingher; Silvia Piccinini; Girolamo Crisi
Journal:  J Comput Assist Tomogr       Date:  2014 Sep-Oct       Impact factor: 1.826

4.  Quantitative MR perfusion parameters related to survival time in high-grade gliomas.

Authors:  Roberto Sanz-Requena; Antonio Revert-Ventura; Luis Martí-Bonmatí; Angel Alberich-Bayarri; Gracián García-Martí
Journal:  Eur Radiol       Date:  2013-07-10       Impact factor: 5.315

5.  Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma.

Authors:  Kathleen M Schmainda; Melissa Prah; Jennifer Connelly; Scott D Rand; Raymond G Hoffman; Wade Mueller; Mark G Malkin
Journal:  Neuro Oncol       Date:  2014-01-15       Impact factor: 12.300

6.  Comparison of the Diagnostic Accuracy of DSC- and Dynamic Contrast-Enhanced MRI in the Preoperative Grading of Astrocytomas.

Authors:  T B Nguyen; G O Cron; K Perdrizet; K Bezzina; C H Torres; S Chakraborty; J Woulfe; G H Jansen; J Sinclair; R E Thornhill; C Foottit; B Zanette; I G Cameron
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-30       Impact factor: 3.825

7.  Early biomarkers from dynamic contrast-enhanced magnetic resonance imaging to predict the response to antiangiogenic therapy in high-grade gliomas.

Authors:  Francesca Piludu; Simona Marzi; Andrea Pace; Veronica Villani; Alessandra Fabi; Carmine Maria Carapella; Irene Terrenato; Anna Antenucci; Antonello Vidiri
Journal:  Neuroradiology       Date:  2015-09-12       Impact factor: 2.804

8.  Different diagnostic values of imaging parameters to predict pseudoprogression in glioblastoma subgroups stratified by MGMT promoter methylation.

Authors:  Ra Gyoung Yoon; Ho Sung Kim; Wooyul Paik; Woo Hyun Shim; Sang Joon Kim; Jeong Hoon Kim
Journal:  Eur Radiol       Date:  2016-04-05       Impact factor: 5.315

Review 9.  Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Authors:  P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

Review 10.  Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review.

Authors:  Anna K Heye; Ross D Culling; Maria Del C Valdés Hernández; Michael J Thrippleton; Joanna M Wardlaw
Journal:  Neuroimage Clin       Date:  2014-09-10       Impact factor: 4.881

View more
  16 in total

1.  Repeatability of dynamic contrast enhanced vp parameter in healthy subjects and patients with brain tumors.

Authors:  Moran Artzi; Gilad Liberman; Deborah T Blumenthal; Felix Bokstein; Orna Aizenstein; Dafna Ben Bashat
Journal:  J Neurooncol       Date:  2018-11-03       Impact factor: 4.130

2.  Comparison of T1 mapping and fixed T1 method for dynamic contrast-enhanced MRI perfusion in brain gliomas.

Authors:  G M Conte; L Altabella; A Castellano; V Cuccarini; A Bizzi; M Grimaldi; A Costa; M Caulo; A Falini; N Anzalone
Journal:  Eur Radiol       Date:  2019-04-10       Impact factor: 5.315

3.  Investigating dynamic susceptibility contrast-enhanced perfusion-weighted magnetic resonance imaging in posterior fossa tumors: differences and similarities with supratentorial tumors.

Authors:  Simona Gaudino; Massimo Benenati; Matia Martucci; Annibale Botto; Amato Infante; Antonio Marrazzo; Antonia Ramaglia; Giammaria Marziali; Pamela Guadalupi; Cesare Colosimo
Journal:  Radiol Med       Date:  2020-01-08       Impact factor: 3.469

4.  T1-weighted dynamic contrast-enhanced brain magnetic resonance imaging: A preliminary study with low infusion rate in pediatric patients.

Authors:  Bruno-Bernard Rochetams; Bénédicte Marechal; Jean-Philippe Cottier; Kathleen Gaillot; Catherine Sembely-Taveau; Dominique Sirinelli; Baptiste Morel
Journal:  Neuroradiol J       Date:  2017-05-30

5.  Volumetric Measurement of Relative CBV Using T1-Perfusion-Weighted MRI with High Temporal Resolution Compared with Traditional T2*-Perfusion-Weighted MRI in Postoperative Patients with High-Grade Gliomas.

Authors:  M Seo; K-J Ahn; Y Choi; N-Y Shin; J Jang; B-S Kim
Journal:  AJNR Am J Neuroradiol       Date:  2022-05-26       Impact factor: 4.966

6.  Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients.

Authors:  Jung Youn Kim; Ji Eun Park; Youngheun Jo; Woo Hyun Shim; Soo Jung Nam; Jeong Hoon Kim; Roh-Eul Yoo; Seung Hong Choi; Ho Sung Kim
Journal:  Neuro Oncol       Date:  2019-02-19       Impact factor: 12.300

7.  Standardized acquisition and post-processing of dynamic susceptibility contrast perfusion in patients with brain tumors, cerebrovascular disease and dementia: comparability of post-processing software.

Authors:  Manuel Alexander Schmidt; Michael Knott; Philip Hoelter; Tobias Engelhorn; Elna Marie Larsson; Than Nguyen; Marco Essig; Arnd Doerfler
Journal:  Br J Radiol       Date:  2019-10-24       Impact factor: 3.039

8.  Machine learning assisted DSC-MRI radiomics as a tool for glioma classification by grade and mutation status.

Authors:  Carole H Sudre; Jasmina Panovska-Griffiths; Eser Sanverdi; Sebastian Brandner; Vasileios K Katsaros; George Stranjalis; Francesca B Pizzini; Claudio Ghimenton; Katarina Surlan-Popovic; Jernej Avsenik; Maria Vittoria Spampinato; Mario Nigro; Arindam R Chatterjee; Arnaud Attye; Sylvie Grand; Alexandre Krainik; Nicoletta Anzalone; Gian Marco Conte; Valeria Romeo; Lorenzo Ugga; Andrea Elefante; Elisa Francesca Ciceri; Elia Guadagno; Eftychia Kapsalaki; Diana Roettger; Javier Gonzalez; Timothé Boutelier; M Jorge Cardoso; Sotirios Bisdas
Journal:  BMC Med Inform Decis Mak       Date:  2020-07-06       Impact factor: 2.796

9.  Comparative evaluation of cerebral gliomas using rCBV measurements during sequential acquisition of T1-perfusion and T2*-perfusion MRI.

Authors:  Jitender Saini; Rakesh Kumar Gupta; Manoj Kumar; Anup Singh; Indrajit Saha; Vani Santosh; Manish Beniwal; Thennarasu Kandavel; Marc Van Cauteren
Journal:  PLoS One       Date:  2019-04-24       Impact factor: 3.240

10.  Inter-observer reproducibility of quantitative dynamic susceptibility contrast and diffusion MRI parameters in histogram analysis of gliomas.

Authors:  Hildebrand Dijkstra; Paul E Sijens; Anouk van der Hoorn; Peter Jan van Laar
Journal:  Acta Radiol       Date:  2019-06-03       Impact factor: 1.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.